Featured Stories

Don't Wait Until it's too Late


Considering your sample size prior to moving into the preclinical phase will reap big benefits further down your development program timeline.

Insights into Biosimilar Development


We are committed to providing testing and regulatory support to companies developing biosimilar products. Recently published articles highlight our insights and key considerations for biosimilar companies.

Find Efficiencies While Retaining Visibility


When pressure comes to increase efficiency, you may turn to insourcing, outsourcing or a mix of both. Keeping visibility of your testing programs, however, is still important. RightSource helps you find balance between these options to reduce costs, retain visibility and focus on your core competencies.

CIRM 2.0: Funding for Translational Research Projects


Charles River entered a collaboration with Quintiles and City of Hope, with funding from the California Institute for Regenerative Medicine (CIRM), to establish the Translating Center in San Diego, CA, which offers end-to-end nonclinical, clinical and manufacturing services for stem-cell-based projects.

See Posters in a New Light!


This video presentation of our poster, presented at Neuroscience 2016, outlines how touchscreen testing and MR spectroscopy were used to detect reduced cognition and altered brain metabolites in the CVN mouse model of Alzheimer's disease.

Displaying results 41-50 (of 107)
 |<  <  1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10  >  >|